Clinical Trial Update: A Study to Assess Adverse Events and Change in Disease Activity in Pediatric Participants (Age 6 Months to <2 Years) With Functional Constipation Who Are Treated With Linaclotide [Phase 2]

View source ↗

Summary

Phase 2 study evaluating safety (adverse events) and change in disease activity of linaclotide in children aged 6 months to under 2 years with functional consti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Functional Constipation

Drugs mentioned

• Linzess (linaclotide)

Snippet

Sponsor: AbbVie | Conditions: Functional Constipation | Phase 2 | Status: COMPLETED | Results posted: 2026-01-06